COVID-19 Clinical Neuroscience Study (COVID-CNS)

Addressing the urgent need to understand the biological causes of neurological and neuropsychiatric complications in hospitalised COVID-19 patients.

Tel: 07385462640 / 07377374954

About the study

The COVID-19 Clinical Neuroscience Study (COVID-CNS) is a £2.3m UKRI study jointly led by researchers at the University of Liverpool and King's College London. Acute neurological and neuropsychiatric complications of COVID-19 affect up to 20-30% of hospitalised patients. In collaboration with CoroNerve and ISARIC-4C study, we will identify these patients, and those that have received the COVID-19 vaccination, and invite them to join COVID-CNS, part of the COVID-19 section of the NIHR BioResource.

Watch the COVID-CNS team discuss the study

The study looks to investigate what is driving brain complications in patients with COVID-19 and why do some people develop neurological or neuropsychiatric symptoms whilst others do not.

Latest from @covidcns